Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. 

CEO
Julie So-Young Kim
CEOJulie So-Young Kim
Employees
47,029
Employees47,029
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,029
Employees47,029

TAK Key Statistics

Market cap
50.62B
Market cap50.62B
Price-Earnings ratio
-55.67
Price-Earnings ratio-55.67
Dividend yield
3.82%
Dividend yield3.82%
Average volume
2.68M
Average volume2.68M
High today
$15.98
High today$15.98
Low today
$15.75
Low today$15.75
Open price
$15.75
Open price$15.75
Volume
2.77M
Volume2.77M
52 Week high
$18.90
52 Week high$18.90
52 Week low
$12.99
52 Week low$12.99

TAK News

Nikkei Asian Review 6h
Takeda's 1st female CEO leans into AI to shape biopharma business - Nikkei Asia

...

Takeda's 1st female CEO leans into AI to shape biopharma business - Nikkei Asia
TipRanks 10h
Takeda Shareholders Approve Dividend and Board Slate at 150th Annual Meeting

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

TipRanks 2d
Takeda CEO Christophe Weber retires, Julie Kim succeeds

Takeda (TAK) announced that Julie Kim was officially appointed Takeda’s representative director, president and CEO. During the annual general meeting of shareho...

Analyst ratings

67%

of 15 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

More TAK News

Nasdaq 3d
Takeda Names Julie Kim CEO As Christophe Weber Retires

(RTTNews) - Takeda Pharmaceutical Co. Ltd. (TAK, 4502.T) announced on Wednesday that it has appointed Julie Kim as President and CEO, completing an 18-month lea...

Takeda Names Julie Kim CEO As Christophe Weber Retires
TipRanks 3d
Takeda Names Julie Kim CEO and Strengthens Board for Next Growth Phase

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

TipRanks 3d
Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib

Takeda (TAK) Canada is pleased to announce positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib, an inves...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.